Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Sanofi

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.

Sanofi

Sanofi and GSK share positive data for two COVID-19 booster vaccine trials

Sanofi and GSK share positive data for two COVID-19 booster vaccine trials Sanofi and GSK have jointly developed a next-generation COVID-19 booster vaccine candidate, based on Sanofi’s recombinant Beta variant antigen and combined with GSK’s pandemic adjuvant. ... BioNTech’s booster or the Sanofi/GSK first-generation

Finalists 2022

for Sanofi. Accelerated Virtual Consensus Programme: Multiple Sclerosis and the COVID-19 Vaccination. ... by Lucid Group. for Sanofi. MS in the 21st Century: ‘myMS’ Tools to Empower Patients in Shared-Care Decisions.

Sanofi and Regeneron receives FDA priority review for prurigo nodularis

Sanofi and Regeneron receives FDA priority review for prurigo nodularis The US Food and Drug Administration (FDA) has accepted priority review of Sanofi and Regeneron’s jointly developed Dupixent (dupilumab) to treat adults with prurigo nodularis.

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC The National Institute for Health and Care Excellence (NICE) has recommended Sanofi and Regeneron’s Libtayo (cemiplimab) for patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC). ... Fleur Chandler, head of market access

Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment

Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment Sanofi and Regeneron have received approval from the US Food and Drug Administration (FDA) for the use of Dupixent (dupilumab) as a treatment for patients with eosinophilic oesophagitis (EoE). ... John Reed, global head of R&D, Sanofi, said: “Our phase

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
KVA

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...